Keisuke Shirai

5.4k total citations
93 papers, 2.0k citations indexed

About

Keisuke Shirai is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keisuke Shirai has authored 93 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 28 papers in Molecular Biology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keisuke Shirai's work include Cancer Immunotherapy and Biomarkers (24 papers), Lung Cancer Treatments and Mutations (17 papers) and Immunotherapy and Immune Responses (11 papers). Keisuke Shirai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (24 papers), Lung Cancer Treatments and Mutations (17 papers) and Immunotherapy and Immune Responses (11 papers). Keisuke Shirai collaborates with scholars based in United States, Japan and Australia. Keisuke Shirai's co-authors include Muhammad Zubair Afzal, Elizabeth Garrett‐Mayer, Konstantin H. Dragnev, John T. Lucas, Besim Öğretmen, Codruța Chiuzan, Paul E. O’Brien, Anand K. Sharma, Yuhe Zhang and Yuichi Kobayashi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Keisuke Shirai

86 papers receiving 1.9k citations

Peers

Keisuke Shirai
Wen‐Yu Chuang Taiwan
Peng Xu China
Thierry Lesimple France
Marc Moncrieff United Kingdom
Mattheos Bobos Greece
Yukinori Takenaka Japan
Kristian Ikenberg Switzerland
Darya Buehler United States
Ethan S. Sokol United States
Wen‐Yu Chuang Taiwan
Keisuke Shirai
Citations per year, relative to Keisuke Shirai Keisuke Shirai (= 1×) peers Wen‐Yu Chuang

Countries citing papers authored by Keisuke Shirai

Since Specialization
Citations

This map shows the geographic impact of Keisuke Shirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Shirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Shirai more than expected).

Fields of papers citing papers by Keisuke Shirai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Shirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Shirai. The network helps show where Keisuke Shirai may publish in the future.

Co-authorship network of co-authors of Keisuke Shirai

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Shirai. A scholar is included among the top collaborators of Keisuke Shirai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Shirai. Keisuke Shirai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masuda, Yu, et al.. (2025). Prepregnancy obesity is an independent risk factor for neonatal vitamin K deficiency at birth. Nutrition. 142. 112954–112954.
2.
Zhang, Ze, Kartik Sehgal, Rondi A. Butler, et al.. (2024). Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors. Epigenomics. 16(11-12). 799–807. 2 indexed citations
3.
Shirai, Keisuke, Masashi Hamaya, Atsushi Hashimoto, et al.. (2024). Vision-Language Interpreter for Robot Task Planning. 2051–2058. 10 indexed citations
4.
5.
Shirai, Keisuke, et al.. (2024). A neonatal mouse model of meconium peritonitis generated using human meconium slurry. Pediatric Research. 97(5). 1742–1749.
6.
Searles, Tyler G., Tiffany Chen, J. Louise Lines, et al.. (2024). Depletion of conventional CD4+ T cells is required for robust priming and dissemination of tumor antigen-specific CD8+ T cells in the setting of anti-CD4 therapy. Journal for ImmunoTherapy of Cancer. 12(11). e010170–e010170. 4 indexed citations
7.
8.
Shirai, Keisuke, et al.. (2023). Towards Flow Graph Prediction of Open-Domain Procedural Texts. 87–96. 1 indexed citations
9.
10.
Han, Jichang, Yanding Zhao, Keisuke Shirai, et al.. (2021). Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy. Nature Cancer. 2(3). 300–311. 91 indexed citations
11.
Agarwala, Sanjiv S., Merrick I. Ross, Jonathan S. Zager, et al.. (2020). 1125P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Results in patients naïve to immune checkpoint blockade. Annals of Oncology. 31. S756–S756. 3 indexed citations
12.
Zager, Jonathan S., Amod Sarnaik, Shari Pilon‐Thomas, et al.. (2020). 1123P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade. Annals of Oncology. 31. S755–S756. 4 indexed citations
13.
Day, Terry A., Keisuke Shirai, Paul E. O’Brien, et al.. (2018). Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clinical Cancer Research. 25(4). 1156–1164. 67 indexed citations
14.
Afzal, Muhammad Zubair, Rodwell Mabaera, & Keisuke Shirai. (2018). Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone. Journal for ImmunoTherapy of Cancer. 6(1). 13–13. 24 indexed citations
15.
Bailey, Stefanie R., Michelle H. Nelson, Kinga Majchrzak, et al.. (2017). Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nature Communications. 8(1). 1961–1961. 73 indexed citations
16.
Yamazaki, Katsumi, et al.. (2010). Electromagnetic Field Analysis for Assist Effects of Permanent Magnets in Salient-Pole Synchronous Generators. IEEJ Transactions on Industry Applications. 130(10). 1182–1188. 2 indexed citations
17.
Lucas, John T., et al.. (2010). Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematological Oncology. 29(2). 100–106. 89 indexed citations
18.
Watkins, John M., Keisuke Shirai, Jennifer L. Harper, et al.. (2010). Toxicity, Response Rates and Survival Outcomes of Induction Cisplatin and Irinotecan Followed by Concurrent Cisplatin, Irinotecan and Radiotherapy for Locally Advanced Esophageal Cancer. Japanese Journal of Clinical Oncology. 41(3). 334–342. 6 indexed citations
19.
Watkins, John M., Keisuke Shirai, Amy E. Wahlquist, et al.. (2010). Cisplatin/Irinotecan Versus Carboplatin/Paclitaxel as Definitive Chemoradiotherapy for Locoregionally Advanced Esophageal Cancer. American Journal of Clinical Oncology. 33(4). 346–352. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Yu Chuang Breakdown of academic impact, for papers by Peng Xu Breakdown of academic impact, for papers by Thierry Lesimple Breakdown of academic impact, for papers by Marc Moncrieff Breakdown of academic impact, for papers by Mattheos Bobos Breakdown of academic impact, for papers by Yukinori Takenaka Breakdown of academic impact, for papers by Kristian Ikenberg Breakdown of academic impact, for papers by Darya Buehler Breakdown of academic impact, for papers by Ethan S. Sokol
Rankless by CCL
2026